Gamma Ventral Capsulotomy for Obsessive Compulsive Disorder: A Placebo-Controlled, Double-Blind Clinical Trial

被引：0

作者：

Lopes, Antonio C. ^{[1
]}

Batistuzzo, Marcelo C. ^{[1
]}

Canteras, Miguel M. ^{[2
]}

Joaquim, Marines A. ^{[1
]}

de Mathis, Maria E. ^{[1
]}

Hoexter, Marcelo Q. ^{[1
]}

Greenberg, Benjamin D. ^{[3
]}

Noren, Georg ^{[4
]}

Rasmussen, Steven A. ^{[3
]}

Shavitt, Roseli G. ^{[1
]}

Miguel, Euripedes C. ^{[1
]}

机构：

[1] Univ Sao Paulo, Sch Med, Dept Psychiat, Sao Paulo, Brazil

[2] Santa Paula Hosp, Inst Neurol Radiosurg, Sao Paulo, Brazil

[3] Brown Univ, Dept Psychiat & Human Behav, Warren Alpert Med Sch, Providence, RI 02912 USA

[4] Brown Univ, Dept Clin Neurosci Neurosurg, Warren Alpert Med Sch, Providence, RI 02912 USA

来源：

BIOLOGICAL PSYCHIATRY | 2013年 / 73卷 / 09期

关键词：

Obsessive-compulsive disorder; Radiosurgery; Placebo effect; Randomized Controlled Trial; Neurosurgery;

D O I：

暂无

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

103

引用

页码：33S / 33S

页数：1

共 50 条

[31] Granisetron-mediated augmentation of sertraline therapeutic effect in obsessive-compulsive disorder: a double-blind placebo-controlled, randomized clinical trial
Ghobadian, Ala
Mokhtari, Saba
Shariati, Behnam
Kamalzadeh, Leila
Shati, Mohsen
Ardebili, Mehrdad Eftekhar
Yarahmadi, Masoomeh
Shalbafan, Mohammadreza
BMC PHARMACOLOGY & TOXICOLOGY, 2022, 23 (01):
[32] Gamma Ventral Capsulotomy in Intractable Obsessive-Compulsive Disorder
Rasmussen, Steven A.
Noren, Georg
Greenberg, Benjamin D.
Marsland, Richard
McLaughlin, Nicole C.
Malloy, Paul J.
Salloway, Stephen P.
Strong, David R.
Eisen, Jane L.
Jenike, Michael A.
Rauch, Scott L.
Baer, Lee
Lindquist, Christer
BIOLOGICAL PSYCHIATRY, 2018, 84 (05) : 355 - 364
[33] Reboxetine Combination Therapy With Fluoxetine in Moderate to Severe Obsessive-Compulsive Disorder: A Placebo-Controlled, Double-Blind, Randomized Trial
Tilaki, Erfaneh Hajian
Hasanzadeh, Alireza
Shalbafan, Mohammadreza
Moghaddam, Hossein Sanjari
Shamabadi, Ahmad
Boroon, Mahsa
Akhondzadeh, Shahin
CLINICAL NEUROPHARMACOLOGY, 2023, 46 (05) : 175 - 180
[34] Naproxen adjunct to fluoxetine for moderate-to-severe obsessive-compulsive disorder: A randomized, double-blind, placebo-controlled trial
Shamabadi, Ahmad
Motavalian, Zahra
Farahmand, Yalda
Farahmand, Kimia
Arabzadeh Bahri, Razman
Askari, Sanaz
Ansari, Sahar
Fallahzadeh, Mohammadali
Shalbafan, Mohammdreza
Akhondzadeh, Shahin
PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2024, 78 (12) : 810 - 817
[35] Duloxetine Augmentation in Resistant Obsessive-Compulsive Disorder A Double-Blind Controlled Clinical Trial
Mowla, Arash
Boostani, Sanaz
Dastgheib, Seyed Ali
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2016, 36 (06) : 720 - 723
[36] A double-blind placebo-controlled trial of risperidone in autistic disorder
McDougle, C
Aman, MG
McCracken, JT
Scahill, L
Tierney, E
Vitiello, B
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S327 - S328
[37] Double-blind, placebo-controlled trial of venlafaxine for panic disorder
Pollack, MH
Worthington, JJ
Otto, MW
Smoller, JW
Maki, KM
Rudolph, R
Rosenbaum, JF
PSYCHOPHARMACOLOGY BULLETIN, 1996, 32 (03) : 496 - 496
[38] Is mirtazapine augmentation effective for patients with obsessive-compulsive disorder who failed to respond to sertraline monotherapy? A placebo-controlled, double-blind, clinical trial
Mowla, Arash
Baniasadipour, Haniyeh
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2023, 38 (01) : 4 - 8
[39] Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study
Hollander, E
Rossi, NB
Sood, E
Pallanti, S
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2003, 6 (04): : 397 - 401
[40] Paroxetine in the treatment of obsessive-compulsive disorder: randomized, double-blind, placebo-controlled study in Japanese patients
Kamijima, K
Murasaki, M
Asai, M
Higuchi, T
Nakajima, T
Taga, C
Matsunaga, H
PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2004, 58 (04) : 427 - 433

← 1 2 3 4 5 →